Voting the Proxy - voting deadline and raising
Voting the Proxy - voting deadline and raising capital
Date: The proxy statement submitted to SEC it states: Votes submitted electronically must be received by 12:00 a.m., Pacific Time, on July 22, 2020
Case For:
1 - Need to raise capital to up-list to NASDAQ which should raise the stock price and inject some stability in the price as compared to the OTC
2 - Need to fund ongoing trials to keep the CCR5 pipeline moving as larger and better resourced companies will compete for the opportunity.
3 - It costs too much to raise capital via loans, just look at the March round of $17 MM funding at 10% annual interest accrual.
4 - The dilution likely has less impact than folks project as the stock will move on price momentum and price perception and less on current underlying financial value. This is very relevant today in current NASDAQ pricing, lets hope the current bubble doesn't burst before CYDY uplists.
5 - Since I have been watching the stock, early 2020 NP has demonstrated he is very conservative on spending and share dilution. In the call Thursday he gave an clear indication of this when he stated how the decision was made to select a distribution partner for LLM to meet the Covid need. They went with a company that has a good distribution network not buying a lot of extras. It is up to individual investors to determine the merits of the decision but on the surface it looks like a decision to not give away the farm upfront.
1
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SmartFinancial Announces Upcoming Earnings Release SmartFinancial, Inc. (NYSE: SMBK) has revealed important details regarding its Fourth Quarter earnings for the year 2024. This is an exciting time for investors and stakeholders as the company prepares to share insights into its financial performance. Earnings Release Date and Conference Call Information The earnings...
Continue Reading
IntouchCX Strengthens Trust and Safety Solutions Through Acquisition IntouchCX has recently made headlines with its acquisition of WebPurify, a leading provider of innovative content moderation solutions that harness the power of artificial intelligence. This strategic move represents a significant advancement in IntouchCX's mission to redefine Trust and Safety solutions,...
Continue Reading
Y-mAbs Therapeutics Engages Investors at Upcoming Conferences This September, Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB), a key player in the biopharmaceutical industry, is poised to attract investor interest. The company is known for its innovative radioimmunotherapy and antibody-based treatments designed to transform cancer care. Michael Rossi, the energetic CEO of...
Continue Reading
Overview of CorVel's Financial Performance CorVel Corporation (NASDAQ: CRVL) recently unveiled impressive results for the quarter and fiscal year, showcasing strong revenue gains and enhanced earnings metrics. The quarterly revenue hit $232 million, a notable rise from $207 million compared to the same quarter last year. This upward trend is mirrored across the fiscal...
Continue Reading
IQAX eBL Interoperability Approval Highlights IQAX Limited has made significant strides in enhancing its electronic bill of lading (eBL) solution by receiving official approval from the International Group of P&I Clubs (IG P&I Clubs). This approval affirms the capabilities of IQAX eBL's interoperable addendum, empowering users to perform eBL transactions across different...
Continue Reading